MedTrace Logo

Arthrocentesis Versus Operative Arthroscopy Treatment of TMJ Internal Derangement (TMJ)

NCT04308460 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-03-16

No results posted yet for this study

Summary

Introduction: Temporomandibular disorders (TMDs) are relatively common conditions and internal derangement is the most common among them. Different methods have been suggested for treatment , beginning with conservative approaches ending with surgery. Nowadays, arthroscopy and arthrocentesis have eliminated the use of many of the more complex surgical procedures. Despite such advancements, there is lack of prospective, randomized, clinical studies to support the use of either both. In doing the necessary studies, and comparing the results, it will be important to develop standardized patient selection criteria and treatment options to be used by all investigators.

Objectives: To compare between arthrocentesis and operative arthroscopy in the management of patients with internal derangement of temporomandibular joint stage II and III Wilkes.

Materials and Methods: a prospective study was done on 40 patients with temporomandibular joint internal derangement and were divided into 2 groups, 20 patients were treated with arthrocentesis and 20 patients were treated with operative arthroscopy.

Conditions

  • Temporomandibular Joint Disc Displacement
  • Temporomandibular Joint Disorders

Interventions

PROCEDURE

arthrocentesis

lavage of the temporomandibular joint was done

PROCEDURE

operative arthroscopy

operative intervention inside the temporomandibular joint was done using arthroscope

Sponsors & Collaborators

  • Hams Hamed Abdelrahman

    lead OTHER

Principal Investigators

  • Mohamed H Warda, PhD · Alexandria University

  • Mohamed M Fata, PhD · Alexandria University

  • Ahmed M Medra, PhD · Alexandria University

  • Florencio G Monje, PhD · University Hospital of badajoz, Sapin

  • Aly M Atteya, MS · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-10
Primary Completion
2019-06-10
Completion
2019-12-16

Countries

  • Egypt
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04308460 on ClinicalTrials.gov